PP 8.2 – 00015 Retargeting cytomegalovirus-specific CD8+ cytotoxic T lymphocytes to kill HIV/SIV-infected cells via peptide-MHC Iantibody fusion proteins

• B.C. Rosen,
• M.J. Ricciardi,
• J.J. Louw,
• T.B. Voigt,
• F.D. Laurino,
• A. Yrizarry-Medina,
• C. Panayiotou,
• F. Zhao,
• J. Woolf,
• S.P. Fuchs,
• M.A. Martins,
• M. Farzan,
• D.R. Burton,
• D. Sok,
• E.G. Rakasz,
• R.C. Desrosiers,
• D.I. Watkins

Affiliations

B.C. Rosen

Medical Scientist Training Program, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Pathology, George Washington University School of Medicine, Washington, DC, USA

M.J. Ricciardi

Department of Pathology, George Washington University School of Medicine, Washington, DC, USA

J.J. Louw

Department of Pathology, George Washington University School of Medicine, Washington, DC, USA

T.B. Voigt

Department of Pathology, George Washington University School of Medicine, Washington, DC, USA

F.D. Laurino

Department of Pathology, George Washington University School of Medicine, Washington, DC, USA

A. Yrizarry-Medina

Department of Pathology, George Washington University School of Medicine, Washington, DC, USA

C. Panayiotou

Department of Pathology, George Washington University School of Medicine, Washington, DC, USA

F. Zhao

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA

J. Woolf

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA

S.P. Fuchs

Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA

M.A. Martins

Department of Immunology and Microbiology, UF Scripps Biomedical Research, Jupiter, FL, USA

M. Farzan

Department of Immunology and Microbiology, UF Scripps Biomedical Research, Jupiter, FL, USA

D.R. Burton

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, USA

D. Sok

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA

E.G. Rakasz

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA

R.C. Desrosiers

Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA

D.I. Watkins

Department of Pathology, George Washington University School of Medicine, Washington, DC, USA